Image not available
Chemicals
Mazdutide IBI362 China Suppliers High Purity Peptide Factory
Premium Mazdutide 10MG and 20MG available from leading China suppliers. Our factory provides high-purity GLP-1 and Glucagon dual agonists for effective weight management.
SupplierFuBai Peptidewww.glpfactory.com
Source categories
About this product
Product information from the supplier.
Mazdutide (also identified as IBI362) represents a breakthrough in metabolic pharmacology, engineered as a high-potency dual agonist targeting both the Glucagon-Like Peptide-1 (GLP-1) and Glucagon (GCG) receptors. As a sophisticated analog of the endogenous hormone oxyntomodulin, Mazdutide is designed for once-weekly subcutaneous administration, offering a streamlined therapeutic approach to complex metabolic disorders.
Developed through a strategic collaboration between Eli Lilly and Innovent Biologics, this innovative peptide leverages a synergistic mechanism of action. By simultaneously activating GLP-1 and GCG pathways, Mazdutide effectively reduces appetite while potentially enhancing energy expenditure, providing a comprehensive pharmacological strategy for significant weight management and glycemic control.
Detailed Parameters
| Product Name | Mazdutide (IBI362) | Mechanism | GLP-1 / Glucagon Dual Agonist |
|---|---|---|---|
| Hormone Analog | Oxyntomodulin Analog | Administration | Injectable (Subcutaneous) |
| Frequency | Once-weekly | Primary Target | Weight Loss & Metabolism |
| Developers | Eli Lilly & Innovent Biologics | Category | Genetic Engineering Peptide |
| Main Effects | Appetite Reduction & Energy Increase | Pharmaceutical Grade | High Purity Bio-pharmaceutical |
Key Advantages
Dual Receptor Action
Combines GLP-1 and GCG agonism to target weight loss from two distinct biological pathways for superior results.
Weekly Administration
Engineered for once-weekly dosing, significantly improving patient compliance compared to daily treatments.
Metabolic Synergy
Promotes weight reduction not only by suppressing hunger but by potentially increasing the body's energy expenditure.
Advanced Bio-Engineering
Utilizes cutting-edge genetic engineering techniques to ensure high stability and precise receptor binding.
Precision Design
An optimized analog of oxyntomodulin tailored for maximum pharmacological efficacy in human subjects.
Global R&D Standard
Developed by industry leaders in biologics, ensuring rigorous quality control and clinical validation.
Product Gallery
Management Platforms
Cold Chain Logistics
Strict temperature-controlled storage to maintain peptide stability and biological activity.
Purity Analysis
Advanced HPLC and Mass Spectrometry testing for every batch to ensure pharmaceutical grade purity.
Stability Monitoring
Real-time tracking of peptide degradation rates under various environmental conditions.
Regulatory Compliance
Full adherence to international bio-manufacturing standards and genetic engineering guidelines.
Inventory Precision
Smart warehouse management ensuring FIFO protocols for biological product freshness.
Batch Traceability
Complete digital audit trails from raw amino acid synthesis to final injectable formulation.
Investment Return Comparison
| Feature Metric | Standard Peptides | Mazdutide (Dual Agonist) |
|---|---|---|
| Mechanism Range | Single Receptor | Dual Receptor (GLP-1/GCG) |
| Patient Compliance | Daily/Frequent | Once-Weekly |
| Metabolic Impact | Appetite Suppression | Appetite + Energy Expenditure |
| Weight Loss Potential | Moderate to High | Enhanced Synergy |
| R&D Complexity | Conventional | Advanced Genetic Engineering |
Frequently Asked Questions
Q: What makes Mazdutide different from traditional GLP-1 agonists?
Unlike traditional agonists that only target the GLP-1 receptor, Mazdutide is a dual agonist that targets both GLP-1 and Glucagon (GCG) receptors, potentially increasing energy expenditure alongside appetite reduction.
Q: How is Mazdutide administered in a clinical setting?
Mazdutide is designed as an injectable medication, typically administered via a subcutaneous injection once per week.
Q: What is the role of genetic engineering in the production of Mazdutide?
Genetic engineering allows for the precise synthesis of the peptide sequence, ensuring it functions as a stable analog of oxyntomodulin with optimized binding affinity for target receptors.
Q: Which companies were involved in the development of Mazdutide?
Mazdutide was developed through a collaborative effort between the global pharmaceutical giant Eli Lilly and Innovent Biologics.
Q: How does the dual agonism affect energy expenditure?
The glucagon (GCG) receptor component of the dual agonist is believed to stimulate thermogenesis and increase the rate at which the body burns calories, complementing the weight loss induced by GLP-1.
Q: Is Mazdutide considered a peptide drug?
Yes, Mazdutide is a peptide-based medication, specifically a modified amino acid chain designed to mimic natural hormones for therapeutic effects.
Ready to Access Premium Genetic Engineering Peptides?
Contact UsMore from this supplier
FuBai Peptide
